Intelligent Office

Eye2 logo

Subscribe to Eye²

Eye² Archives


July 23, 2014

In This Edition

Heads Up
ChipSip's SiMEye Wins Technology Award

Smartglasses for Low Vision Users

Next Dimension
Alcon to Enter Smart Lens Market

Intelligent Office

Heads Up

ChipSiP SiMEye Smart Glass Wins Best Choice Award at Computex 2014

ChipSiP Technology Co., a Taiwanese company that is a leader in turnkey SiP (System in Package) technology, announced that its SiMEye Smart Glass has been awarded the Best Choice of Computex Taipei 2014 Award. The SiMEye Smart Glass, designed by ChipSiP's core technology in system miniaturization, features real-time and instant access to information and real-time communications in a compact design. It can be conveniently operated by either gesture or touchpad functions.



Oxford University Researchers Develop Smartglasses for Low Vision Users

Smartglasses developed at Oxford University in England for the registered blind are being used for wearer trials in public spaces for the first time. The Oxford researchers are measuring how their smartglasses can help people with limited vision navigate and avoid walking into obstacles.

"The idea of the smartglasses is to give people with poor vision an aid that boosts their awareness of what's around them—allowing greater freedom, independence and confidence to get about, and a much improved quality of life," said Stephen Hicks, PhD, of the Nuffield Department of Clinical Neurosciences at the University of Oxford, who is leading the development of the glasses.


Next Dimension

Alcon to Enter Smart Lens Market With Technology Licensed from Google

Alcon's entry into the field of smart contact lenses and IOLs, made possible through a licensing agreement with Google announced last week by its parent company, Novartis, gives a significant boost to this small but growing segment of the vision care market.

Under the terms of the licensing deal, which is subject to anti-trust approvals, Google[x] and Alcon will collaborate to develop a "smart lens" that has the potential to address ocular conditions.


Vision Monday

Andrew Karp, Group Editor, Lenses and Technology

Send us news about new optical technologies, provide us with subjects and/or questions for a future Eye² Q&A or let us know what topics you'd like to see covered. Contact Eye²'s Editor Andrew Karp at

Copyright © 2014 VisionMonday. All rights reserved.
Eye² is published by Jobson Medical Information LLC,
100 Avenue of Americas, New York, NY 10013.

To subscribe to other JMI newsletters or to manage your subscription, click here.

To change your email address, reply to this email.
Write "change of address" in the subject line.
Make sure to provide us your old and new address.

To ensure delivery, please be sure to add to
your address book or safe senders list.

Click here if you do not want to receive future emails from Eye².